Olive Kearins

2.8k total citations
56 papers, 1.7k citations indexed

About

Olive Kearins is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Olive Kearins has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 30 papers in Cancer Research and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Olive Kearins's work include Global Cancer Incidence and Screening (47 papers), Breast Cancer Treatment Studies (30 papers) and Breast Lesions and Carcinomas (18 papers). Olive Kearins is often cited by papers focused on Global Cancer Incidence and Screening (47 papers), Breast Cancer Treatment Studies (30 papers) and Breast Lesions and Carcinomas (18 papers). Olive Kearins collaborates with scholars based in United Kingdom, United States and Netherlands. Olive Kearins's co-authors include Gill Lawrence, Matthew Wallis, David Dodwell, Nancy Tappenden, Gordon Wishart, Carlos Caldas, David Greenberg, Jem Rashbass, Elizabeth M. Azzato and Stephen W. Duffy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Cancer.

In The Last Decade

Olive Kearins

54 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olive Kearins United Kingdom	21	898	883	452	249	227	56	1.7k
Linda de Munck Netherlands	22	980 1.1×	947 1.1×	470 1.0×	366 1.5×	150 0.7×	79	1.6k
Stephen G. Ruby United States	14	642 0.7×	576 0.7×	311 0.7×	152 0.6×	232 1.0×	31	1.4k
Gill Lawrence United Kingdom	22	1.1k 1.3×	939 1.1×	452 1.0×	414 1.7×	199 0.9×	58	2.1k
Irma Fredriksson Sweden	22	946 1.1×	805 0.9×	263 0.6×	108 0.4×	148 0.7×	64	1.5k
Maaike de Boer Netherlands	22	1.0k 1.2×	1.2k 1.3×	619 1.4×	486 2.0×	310 1.4×	74	2.1k
Richard J. Bleicher United States	26	1.6k 1.8×	1.2k 1.3×	507 1.1×	535 2.1×	441 1.9×	112	3.0k
Javaid Iqbal Canada	15	1.1k 1.2×	782 0.9×	381 0.8×	134 0.5×	107 0.5×	23	1.8k
Shelley Hwang United States	17	500 0.6×	852 1.0×	544 1.2×	510 2.0×	137 0.6×	34	1.5k
Nina Horowitz United States	16	627 0.7×	674 0.8×	345 0.8×	295 1.2×	134 0.6×	50	1.4k
Bethany L. Niell United States	22	660 0.7×	500 0.6×	527 1.2×	175 0.7×	574 2.5×	62	1.8k

Countries citing papers authored by Olive Kearins

Since Specialization

Citations

This map shows the geographic impact of Olive Kearins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olive Kearins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olive Kearins more than expected).

Fields of papers citing papers by Olive Kearins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olive Kearins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olive Kearins. The network helps show where Olive Kearins may publish in the future.

Co-authorship network of co-authors of Olive Kearins

This figure shows the co-authorship network connecting the top 25 collaborators of Olive Kearins. A scholar is included among the top collaborators of Olive Kearins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olive Kearins. Olive Kearins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taylor‐Phillips, Sian, Chris Stinton, Melina A. Kunar, et al.. (2024). Fatigue and vigilance in medical experts detecting breast cancer. Proceedings of the National Academy of Sciences. 121(11). e2309576121–e2309576121. 4 indexed citations

Maxwell, Anthony, Bridget Hilton, Karen Clements, et al.. (2022). Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study. The Breast. 61. 145–155. 21 indexed citations

Clements, Karen, David Dodwell, Bridget Hilton, et al.. (2022). Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia. BMJ Open. 12(12). e061585–e061585. 3 indexed citations

Cornford, Eleanor, et al.. (2021). Optimum screening mammography reading volumes: evidence from the NHS Breast Screening Programme. European Radiology. 31(9). 6909–6915. 8 indexed citations

Freeman, Karoline, Karen Clements, Bridget Hilton, et al.. (2021). Breast screening atypia and subsequent development of cancer: protocol for an observational analysis of the Sloane database in England (Sloane atypia cohort study).. Apollo (University of Cambridge). 4 indexed citations

Sharma, Nisha, et al.. (2021). The impact of vacuum-assisted excision in the management of indeterminate B3 lesions in the NHS Breast Screening Programme in England. Clinical Radiology. 76(6). 470.e23–470.e29. 9 indexed citations

Johnson, Rebecca, Harbinder Sandhu, David R Ellard, et al.. (2019). Communicating biopsy results from breast screening assessment: current practice in English breast screening centres and staff perspectives of telephoning results. BMJ Open. 9(11). e028683–e028683. 2 indexed citations

Maxwell, Anthony, Karen Clements, Bridget Hilton, et al.. (2018). Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ. European Journal of Surgical Oncology. 44(4). 429–435. 66 indexed citations

Blanks, R G, et al.. (2018). Role of performance metrics in breast screening imaging – where are we and where should we be?. Clinical Radiology. 73(4). 381–388. 4 indexed citations

10.

Patterson, Jacoby, Rebecca Johnson, Harbinder Sandhu, et al.. (2018). Communication of cancer screening results by letter, telephone or in person: A mixed methods systematic review of the effect on attendee anxiety, understanding and preferences. Preventive Medicine Reports. 13. 189–195. 19 indexed citations

11.

Kearins, Olive, et al.. (2015). Contralateral breast cancer: incidence according to ductal or lobular phenotype of the primary. Clinical Radiology. 71(2). 159–163. 9 indexed citations

12.

Cheung, Shan, et al.. (2014). Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS). The Breast. 23(6). 807–811. 18 indexed citations

13.

Bates, T, T. Evans, Catherine Lagord, et al.. (2014). A population based study of variations in operation rates for breast cancer, of comorbidity and prognosis at diagnosis: Failure to operate for early breast cancer in older women. European Journal of Surgical Oncology. 40(10). 1230–1236. 23 indexed citations

14.

Kearins, Olive, et al.. (2013). Patient satisfaction with clinical nurse specialists’ practice. Nursing Standard. 27(37). 41–47. 3 indexed citations

15.

Allgood, P C, S W Duffy, Olive Kearins, et al.. (2011). Explaining the difference in prognosis between screen-detected and symptomatic breast cancers. British Journal of Cancer. 104(11). 1680–1685. 62 indexed citations

16.

Wishart, Gordon, Elizabeth M. Azzato, David Greenberg, et al.. (2010). PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Research. 12(1). R1–R1. 283 indexed citations

17.

Nagtegaal, Irıs D., P C Allgood, Stephen W. Duffy, et al.. (2010). Prognosis and pathology of screen‐detected carcinomas. Cancer. 117(7). 1360–1368. 45 indexed citations

18.

Maxwell, Anthony, Andy Evans, R Carpenter, et al.. (2009). Follow-up for screen-detected ductal carcinoma in situ: Results of a survey of UK centres participating in the Sloane project. European Journal of Surgical Oncology. 35(10). 1055–1059. 4 indexed citations

19.

Wallis, Matthew, et al.. (2008). Non-operative diagnosis—effect on repeat-operation rates in the UK breast screening programme. European Radiology. 19(2). 318–323. 7 indexed citations

20.

Duffy, Stephen W., Irıs D. Nagtegaal, Matthew Wallis, et al.. (2008). Correcting for Lead Time and Length Bias in Estimating the Effect of Screen Detection on Cancer Survival. American Journal of Epidemiology. 168(1). 98–104. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact